| A validated LC-MS/MS method for determination of antiviral prodrug molnupiravir in human plasma and its application for a pharmacokinetic modeling study in healthy Egyptian … AS Gouda, HM Marzouk, MR Rezk, AM Salem, MI Morsi, EG Nouman, ... Journal of Chromatography B 1206, 123363, 2022 | 34 | 2022 |
| FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma M El-Hamamsy, RR Ghali, AS Saad, SM Shaheen, AM Salem OncoTargets and therapy, 6857-6863, 2016 | 12 | 2016 |
| The Association Between the FTO rs9939609 Variant and Malignant Pleural Mesothelioma Risk: A Case–Control Study MS Khella, AM Salem, O Abdel-Rahman, AS Saad Genetic testing and molecular biomarkers 22 (2), 79-84, 2018 | 11 | 2018 |
| Interspecies comparison and radiation effect on pharmacokinetics of BIO 300, a nanosuspension of genistein, after different routes of administration in mice and non-human primates AM Salem, IL Jackson, A Gibbs, Y Poirier, D Newman, A Zodda, ... Radiation Research 197 (5), 447-458, 2022 | 9 | 2022 |
| Development of a multiscale mechanistic modeling framework integrating differential cellular kinetics of CAR T‐cell subsets and immunophenotypes in cancer patients AM Salem, GM Mugundu, AP Singh CPT: Pharmacometrics & Systems Pharmacology 12 (9), 1285-1304, 2023 | 6 | 2023 |
| Reassessing the Pediatric Dosing Recommendations for Unfractionated Heparin Using Real‐World Data: A Pharmacokinetic–Pharmacodynamic Modeling Approach AM Salem, T Niu, C Li, BS Moffett, V Ivaturi, M Gopalakrishnan The Journal of Clinical Pharmacology 62 (6), 733-746, 2022 | 4 | 2022 |
| Pharmacokinetic Modeling Using Real‐World Data to Optimize Unfractionated Heparin Dosing in Pediatric Patients on Extracorporeal Membrane Oxygenation and Evaluate Target … AM Salem, T Smith, J Wilkes, DK Bailly, C Heyrend, M Profsky, ... The Journal of Clinical Pharmacology 64 (1), 30-44, 2024 | 1 | 2024 |
| Model‐based approach to identify predictors of paclitaxel‐induced myelosuppression in “real‐world” administration AM Salem, E Dvergsten, S Karovic, ML Maitland, M Gopalakrishnan CPT: Pharmacometrics & Systems Pharmacology 12 (7), 929-940, 2023 | 1 | 2023 |
| A population pharmacokinetic modeling approach to evaluate the current dosing recommendations of favipiravir in Egyptian subjects A Salem, A Gouda, H Marzouk, M Rezk, A Abdel-Megied International Journal of Infectious Diseases 130, S94, 2023 | 1 | 2023 |
| Pharmacogenetics of warfarin dose requirements in the African continent: a systematic review. A Salem, I Abdelgawad, M Tammam, M Solayman PHARMACOTHERAPY 38 (7), E77-E78, 2018 | 1 | 2018 |
| Pharmacometric Model-Based Real-World Data Driven Framework to Refine Unfractionated Heparin Dosing in Pediatric Population A Salem | | 2024 |
| A Pharmacokinetic Modeling Approach to Evaluate the Current Dosing Recommendations for Molnupiravir, a Novel Oral SARS-CoV-2 Antiviral, in the Egyptian Population A Salem, A Gouda, H Marzouk, M Rezk, A Abdel-Megied 2022 ACCP Virtual Poster Symposium (May 24 and 25), 2022 | | 2022 |
| A MULTISCALE MECHANISTIC MODEL DESCRIBES DIFFERENTIAL CELLULAR KINETICS OF CD4 AND CD8 SUBSETS OF CAR-T CELL PRODUCT IN CANCER PATIENTS. A Salem, G Mugundu, A Singh CLINICAL PHARMACOLOGY & THERAPEUTICS 111, S44-S44, 2022 | | 2022 |
| A MECHANISTIC MODELING FRAMEWORK INTEGRATES LONGITUDINAL CHANGES IN CAR-T CELL IMMUNOPHENOTYPES TO CHARACTERIZE CELLULAR KINETICS IN CANCER PATIENTS. A Salem, G Mugundu, A Singh CLINICAL PHARMACOLOGY & THERAPEUTICS 111, S44-S44, 2022 | | 2022 |
| P3. 03-041 FAS/FASL Genetic Polymorphisms Impact on Clinical Outcome of Malignant Pleural Mesothelioma: Topic: Mesothelioma Clinical A Salem, M El-Hamamsy, R Ghali, A Saad, S Shaheen Journal of Thoracic Oncology 12 (1), S1370-S1371, 2017 | | 2017 |
